SERUM HBSAG LEVELS DURING PEGINTERFERON ALFA-2A TREATMENT IN HBEAG-POSITIVE CHRONIC HEPATITIS B: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL

被引：0
|
作者：
Kim, Bo Hyun [1 ,2 ]
Kim, Won [3 ]
Song, Fun Young [4 ]
Park, Myoung Hee [4 ]
Yoon, Jung-Hwan [5 ,6 ]
Lee, Youn Jae [7 ]
Park, Sung Jae [7 ]
Jung, Eun Uk [7 ]
Kim, Donghee [8 ]
Kim, Yoon Jun [5 ,6 ]
Lee, Hyo-Suk [5 ,6 ]
机构：
[1] Bundang Jesaeng Gen Hosp, Dept Internal Med, Songnam, South Korea
[2] Bundang Jesaeng Gen Hosp, Hepatol Ctr, Songnam, South Korea
[3] Seoul Metropolitan Govt Seoul Natl Univ Boramae M, Dept Internal Med, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea
[5] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[6] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea
[7] Inje Univ, Paik Hosp, Dept Internal Med, Pusan, South Korea
[8] Seoul Natl Univ Hosp, Gangnam Healthcare Ctr, Inst Healthcare Res, Seoul 110744, South Korea
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
390
引用
收藏
页码：514A / 514A
页数：1
相关论文
共 50 条
  • [31] BASELINE HBSAG LEVELS PREDICT HBSAG LOSS IN HBEAG NEGATIVE BUT NOT IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEGASYS®) AND ADEFOVIR (HEPSERA): AN INTERIM ANALYSIS
    Takkenberg, Bart
    Zaaijer, Hans L.
    de Niet, Annikki
    Weegink, Christine J.
    Terpstra, Valeska
    Koot, Maarten
    Dijkgraaf, Marcel
    Jansen, Peter L.
    Janssen, Harry L.
    Beld, Marcel
    Reesink, Hendrik W.
    HEPATOLOGY, 2009, 50 (04) : 536A - 537A
  • [32] Characterization of Hepatitis B Surface Proteins in HBeAg-positive Patients with Chronic Hepatitis B (CHB) Treated With PegInterferon Alfa-2a (40KD)
    Rinker, Franziska
    Bremer, Corinna M.
    Wiegand, Steffen B.
    Bremer, Birgit
    Manns, Michael P.
    Wedemeyer, Heiner
    Yang, Lei
    Pavlovic, Vedran
    Wat, Cynthia
    Glebe, Dieter
    Kraft, Anke R.
    Cornberg, Markus
    HEPATOLOGY, 2015, 62 : 1196A - 1197A
  • [33] EFFICACY OF PEGINTERFERON ALFA-2A OR ALFA-2B IN TREATMENT OF HBEAG NEGATIVE CHRONIC HEPATITIS B INFECTION
    Karabay, Oguz
    Tuna, Nazan
    Esen, Saban
    HEPATOLOGY, 2011, 54 : 1061A - 1061A
  • [34] The combination of entecavir and peginterferon alfa-2a in HBeAg-positive immune tolerant (IT) adults with chronic hepatitis B virus (HBV) infection: Results of the HBRN IT Trial
    Feld, Jordan J.
    Terrault, Norah
    Belle, Steven H.
    Chung, Raymond T.
    Tsai, Naoky C.
    Khalili, Mandana
    Perrillo, Robert P.
    Cooper, Stewart
    Ghany, Marc G.
    Janssen, Harry L.
    Lok, Anna S.
    HEPATOLOGY, 2017, 66 : 485A - 486A
  • [35] EXTENDING PEGINTERFERON ALFA-2A THERAPY IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B WHO DID NOT ACHIEVE A RESPONSE AT WEEK 48 CAN LEAD TO HBEAG SEROCONVERSION AND HBSAG CLEARANCE
    Chen, Xiao P.
    Chen, Xue-Fu
    Huang, Ji
    Chen, Wen-Li
    Ren, Chen
    Ma, Xiao-jun
    Luo, X-d
    HEPATOLOGY, 2009, 50 (04) : 499A - 499A
  • [36] Serum hepatitis B virus RNA predicts response to peginterferon treatment in HBeAg-positive chronic hepatitis B
    van Campenhout, Margo J. H.
    van Boemmel, Florian
    Pfefferkorn, Maria
    Fischer, Janett
    Deichsel, Danilo
    Boonstra, Andre
    van Vuuren, Anneke J.
    Berg, Thomas
    Hansen, Bettina E.
    Janssen, Harry L. A.
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (06) : 610 - 619
  • [37] PEGINTERFERON LAMBDA FOR THE TREATMENT OF CHRONIC HEPATITIS B (CHB): A PHASE 2B COMPARISON WITH PEGINTERFERON ALFA IN PATIENTS WITH HBeAg-POSITIVE DISEASE
    Chan, H. L.
    Ahn, S. H.
    Chang, T. -T.
    Peng, C. -Y.
    Wong, D.
    Coffin, C. S.
    Lim, S. G.
    Chen, P. -J.
    Janssen, H. L.
    Marcellin, P.
    Serfaty, L.
    Zeuzem, S.
    Cohen, D.
    Critelli, L.
    Xu, D.
    Cooney, E.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S48 - S48
  • [38] Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance
    Sun, J.
    Hou, J. -L.
    Xie, Q.
    Li, X. -H.
    Zhang, J. -M.
    Wang, Y. -M.
    Wang, H.
    Lai, J. -Y.
    Chen, S. -J.
    Jia, J. -D.
    Sheng, J. -F.
    Chan, H. L. Y.
    Wang, J. -F.
    Li, M. K. K.
    Jiang, M.
    Popescu, M.
    Sung, J. J. Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (04) : 424 - 431
  • [39] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Piratvisuth, Teerha
    Lau, George
    Chao, You-Chen
    Jin, Rui
    Chutaputti, Anuchit
    Zhang, Q. -B.
    Tanwandee, Tawesak
    Button, Peter
    Popescu, Matei
    HEPATOLOGY INTERNATIONAL, 2008, 2 (01) : 102 - 110
  • [40] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Teerha Piratvisuth
    George Lau
    You-Chen Chao
    Rui Jin
    Anuchit Chutaputti
    Q.-B. Zhang
    Tawesak Tanwandee
    Peter Button
    Matei Popescu
    Hepatology International, 2008, 2 : 102 - 110
12345